ALX Oncology Holdings Inc. (ALXO)
NASDAQ: ALXO · Real-Time Price · USD
1.585
+0.035 (2.26%)
Jun 10, 2026, 10:36 AM EDT - Market open
ALX Oncology Holdings Market Cap
ALX Oncology Holdings has a market cap or net worth of $213.28 million as of June 10, 2026. Its market cap has increased by 760.61% in one year.
Market Cap
213.28M
Enterprise Value
76.76M
1-Year Change
760.61%
Ranking
Category
Stock Price
$1.59
Market Cap Chart
Since July 17, 2020, ALX Oncology Holdings's market cap has decreased from $1.06B to $213.28M, a decrease of -79.81%. That is a compound annual growth rate of -23.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 9, 2026 | 208.57M | 240.43% |
| Dec 31, 2025 | 61.27M | -30.44% |
| Dec 31, 2024 | 88.08M | -88.13% |
| Dec 29, 2023 | 741.80M | 61.50% |
| Dec 30, 2022 | 459.31M | -47.23% |
| Dec 31, 2021 | 870.34M | -74.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LENZ Therapeutics | 212.90M |
| Cellectis | 210.84M |
| Whitehawk Therapeutics | 208.69M |
| Camp4 Therapeutics | 208.22M |
| Voyager Therapeutics | 207.25M |
| YD Bio | 206.74M |
| Arcturus Therapeutics Holdings | 203.51M |
| Q32 Bio | 201.61M |